Hypogonadism is a medical condition where your body produces insufficient amounts of testosterone, affecting approximately 4-5 million men in the United States. Primary hypogonadism occurs when the testes fail to produce adequate testosterone, while secondary hypogonadism results from problems with the hypothalamus or pituitary gland that control hormone production. Normal testosterone levels range from 300-1,000 ng/dL, and men with levels below 300 ng/dL typically experience symptoms like fatigue, low libido, muscle weakness, and mood changes. Treatment options include testosterone replacement therapy, which can raise levels by 200-400 ng/dL within 3-6 months, and supportive therapies like peptide therapy to optimize natural hormone production. Early diagnosis and treatment can significantly improve quality of life and prevent long-term complications like osteoporosis and cardiovascular disease.
Key Takeaways
- Hypogonadism affects 4-5 million American men, with testosterone levels below 300 ng/dL
- Primary type involves testicular dysfunction, secondary involves brain hormone control issues
- Symptoms include fatigue, low libido, muscle weakness, depression, and cognitive issues
- Testosterone replacement therapy can increase levels by 200-400 ng/dL within 3-6 months
- Peptide therapies like sermorelin can support natural hormone production safely
Types and Causes of Hypogonadism
Primary hypogonadism stems directly from testicular problems that prevent normal testosterone production. Common causes include Klinefelter syndrome (affecting 1 in 500-650 men), mumps orchitis, chemotherapy exposure, and aging-related testicular decline. Men over 40 experience a natural 1-2% annual decrease in testosterone production, which can lead to age-related hypogonadism by their 50s or 60s. Secondary hypogonadism occurs when the hypothalamus or pituitary gland fails to signal proper testosterone production. This type affects roughly 2-3% of men and can result from pituitary tumors, head trauma, chronic opioid use, or severe obesity. Men with a BMI over 30 have 30% lower testosterone levels on average compared to men with normal weight.Recognizing Hypogonadism Symptoms
Physical symptoms of hypogonadism typically develop gradually over months or years. Men report decreased muscle mass and strength, with studies showing 10-15% muscle loss in untreated cases. Sexual symptoms include reduced libido, erectile dysfunction affecting 20-30% of hypogonadal men, and decreased spontaneous erections. Psychological symptoms often appear before physical changes become apparent. Depression occurs in 25-30% of men with low testosterone, while cognitive issues like poor concentration and memory problems affect up to 40% of patients. Sleep disturbances, particularly reduced REM sleep, compound these mental health challenges and create a cycle of worsening symptoms.Treatment Options for Hypogonadism
Testosterone replacement therapy remains the primary treatment for clinically diagnosed hypogonadism. Gel formulations like AndroGel or Testim cost $300-500 monthly in 2026, while testosterone injections range from $50-150 per month. Treatment typically raises testosterone levels by 200-400 ng/dL within 12 weeks, with symptom improvement often beginning within 3-4 weeks. Sermorelin therapy offers an alternative approach by stimulating natural growth hormone production, which can indirectly support testosterone levels. This peptide costs approximately $200-400 monthly and works particularly well for men with secondary hypogonadism. Ipamorelin provides similar benefits with fewer side effects, making it suitable for long-term use. Some patients benefit from combination therapies that include BPC-157 for tissue repair and recovery, or TB-500 for enhanced healing and muscle development. These supportive treatments help optimize the overall response to testosterone therapy and may reduce the required hormone dosage over time.Frequently Asked Questions
What testosterone level indicates hypogonadism?
Testosterone levels below 300 ng/dL generally indicate hypogonadism, though symptoms matter more than numbers alone. The normal range spans 300-1,000 ng/dL, but men can experience symptoms even with levels in the 300-400 range. Two morning blood tests taken on separate days are required for accurate diagnosis, as testosterone levels fluctuate throughout the day and peak in early morning hours.
Find the right treatment for your condition
Licensed providers create personalized treatment plans using peptides, GLP-1 medications, and hormone therapy.
Start Free Assessment →How long does testosterone replacement therapy take to work?
Most men notice initial improvements in energy and mood within 3-4 weeks of starting testosterone replacement therapy. Sexual function typically improves within 6-8 weeks, while muscle mass and strength gains become apparent after 12-16 weeks. Full benefits, including bone density improvements, may take 6-12 months to develop fully. Blood levels stabilize within 4-6 weeks of starting treatment.
Can peptide therapy replace testosterone injections?
Peptide therapy can support natural testosterone production but may not fully replace direct hormone replacement in severe cases. Sermorelin and ipamorelin work best for men with secondary hypogonadism or mild primary cases. These peptides stimulate your body's natural hormone production rather than providing external hormones, making them safer for long-term use with fewer side effects than traditional testosterone therapy.
What are the risks of untreated hypogonadism?
Untreated hypogonadism increases the risk of osteoporosis, with bone density declining 1-3% annually in affected men. Cardiovascular disease risk also rises due to changes in cholesterol levels and increased abdominal fat. Mental health complications include depression, anxiety, and cognitive decline. Muscle mass continues to decrease, leading to frailty and increased fall risk, particularly in older men with long-standing hormone deficiency.
How much does hypogonadism treatment cost in 2026?
Treatment costs vary significantly by method and insurance coverage. Testosterone gels range from $300-500 monthly, while injections cost $50-150 per month. Peptide therapy ranges from $200-400 monthly for most protocols. Insurance typically covers testosterone replacement therapy when medically necessary, but peptide treatments may require out-of-pocket payment. Initial diagnostic testing and monitoring add $200-400 annually to treatment costs.
Sources
- Mulhall JP, et al. Evaluation and management of testosterone deficiency: AUA guideline. Journal of Urology. 2018;200(2):423-432. PMID: 29601923
- Bhasin S, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2018;103(5):1715-1744. PMID: 29562364
- Corona G, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. European Journal of Endocrinology. 2011;165(5):687-701. PMID: 21852391
- Travison TG, et al. The relationship between libido and testosterone levels in aging men. Journal of Clinical Endocrinology & Metabolism. 2006;91(7):2509-2513. PMID: 16670164
- Shores MM, et al. Low serum testosterone and mortality in male veterans. Archives of Internal Medicine. 2006;166(15):1660-1665. PMID: 16908801
- Snyder PJ, et al. Effects of testosterone treatment in older men. New England Journal of Medicine. 2016;374(7):611-624. PMID: 26886521
- Basaria S, et al. Adverse events associated with testosterone administration. New England Journal of Medicine. 2010;363(2):109-122. PMID: 20592293
- Wu FC, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. New England Journal of Medicine. 2010;363(2):123-135. PMID: 20554979
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →